Daban, A., Gonnin, C., Phan, L., Saldmann, A., Granier, C., Lillo-Lelouet, A., . . . Simonaggio, A. Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs). Taylor & Francis Group.
Chicago Style (17th ed.) CitationDaban, A., et al. Preexisting Autoantibodies as Predictor of Immune Related Adverse Events (irAEs) for Advanced Solid Tumors Treated with Immune Checkpoint Inhibitors (ICIs). Taylor & Francis Group.
MLA (9th ed.) CitationDaban, A., et al. Preexisting Autoantibodies as Predictor of Immune Related Adverse Events (irAEs) for Advanced Solid Tumors Treated with Immune Checkpoint Inhibitors (ICIs). Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.